Atmospheric rivers (ARs) reaching high-latitudes in summer contribute to the majority of climatological poleward water vapor transport into the Arctic. This transport has exhibited long term changes over the past decades, which cannot be entirely explained by anthropogenic forcing according to ensemble model responses. Here, through observational analyses and model experiments in which winds are adjusted to match observations, we demonstrate that low-frequency, large-scale circulation changes in the Arctic play a decisive role in regulating AR activity and thus inducing the recent upsurge of this activity in the region.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
March 2024
The projected changes in the hydrological cycle under global warming remain highly uncertain across current climate models. Here, we demonstrate that the observational past warming trend can be utilized to effectively co1nstrain future projections in mean and extreme precipitation on both global and regional scales. The physical basis for such constraints relies on the relatively constant climate sensitivity in individual models and the reasonable consistency of regional hydrological sensitivity among the models, which is dominated and regulated by the increases in atmospheric moisture.
View Article and Find Full Text PDFStudies of the multi-scale climate variability of the Asian monsoon are essential to an advanced understanding of the physical processes of the global climate system. In this paper, the progress achieved in this field is systematically reviewed, with a focus on the past several years. The achievements are summarized into the following topics: (1) the onset of the South China Sea summer monsoon; (2) the East Asian summer monsoon; (3) the East Asian winter monsoon; and (4) the Indian summer monsoon.
View Article and Find Full Text PDFHigh levels of fine particulate matter (PM) pose a severe air pollution challenge in China. Both land use changes and anthropogenic emissions can affect PM2.5 concentrations.
View Article and Find Full Text PDFBackground: Nemonoxacin, a novel nonfluorinated quinolone, has broad-spectrum antibacterial activity, including activity against antibiotic-resistant strains, and was developed for treating community-acquired pneumonia (CAP). This report provides an integrated safety summary of oral nemonoxacin from two phase II and one phase III clinical studies.
Methods: Patients with mild CAP were randomized for treatment with nemonoxacin 500 mg (NEMO-500MG), nemonoxacin 750 mg (NEMO-750MG), or levofloxacin 500 mg (LEVO), orally, once daily, for 7-10 days.
The present study investigates the modulation of the East Asian winter monsoon (EAWM) in the impacts of El Niño on the wintertime rainfall anomalies in southeastern China. Here, the variability of the EAWM that is independent of ENSO is considered, which is referred to as EAWM with a strong EAWM denoting anomalous northerly winds. Results demonstrate that strong (weak) EAWM weakens (enhances) the positive rainfall anomalies in southeastern China induced by El Niño, because anomalous downward motion over the western North Pacific (WNP) associated with El Niño is weakened (strengthened) by strong (weak) EAWM.
View Article and Find Full Text PDFBackground/purpose: Nemonoxacin is a novel nonfluorinated quinolone with excellent in vitro activity against most pathogens in community-acquired pneumonia (CAP), especially Gram-positive isolates. The purpose of this study was to assess the efficacy and safety of nemonoxacin compared with levofloxacin in patients with CAP.
Methods: A phase 3, multicenter, randomized (2:1) controlled trial was conducted in adult CAP patients receiving nemonoxacin 500 mg or levofloxacin 500 mg orally once daily for 7-10 days.
Purpose: This study aimed to evaluate the impact of previous antibiotic exposure and the influence of time interval since exposure on the evolution of antibiotic-resistant infections.
Methods: We retrospectively analyzed 167 mechanically ventilated patients with nosocomial infections over a 3-year period, with focus on infections in the bloodstream, urinary tract, lower respiratory tract, and surgical sites.
Results: Of 167 patients, 62% were confirmed as antibiotic resistant.
Antimicrob Agents Chemother
October 2010
Nemonoxacin, a novel nonfluorinated quinolone, exhibits potent in vitro and in vivo activities against community-acquired pneumonia (CAP) pathogens, including multidrug-resistant Streptococcus pneumoniae. Patients with mild to moderate CAP (n = 265) were randomized to receive oral nemonoxacin (750 mg or 500 mg) or levofloxacin (500 mg) once daily for 7 days. Clinical responses were determined at the test-of-cure visit in intent-to-treat (ITT), clinical per protocol (PPc), evaluable-ITT, and evaluable-PPc populations.
View Article and Find Full Text PDFBackground/purpose: Patients on prolonged mechanical ventilation in Taiwan are stepped down to a respiratory care ward (RCW) for further respiratory care. Only a few patients in the RCW can ultimately be weaned and discharged. In this study, we tried to determine factors that predict mortality and readmission of these patients in the post-discharge period.
View Article and Find Full Text PDF